The management of superficial bladder cancer

被引：26

作者：

Oosterlinck, W ^{[1
]}

机构：

[1] Ghent Univ Hosp, Dept Urol, B-9000 Ghent, Belgium

来源：

BJU INTERNATIONAL | 2001年 / 87卷 / 02期

关键词：

D O I：

10.1046/j.1464-410x.2001.00948.x

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：135 / 140

页数：6

共 43 条

[1] Sequential bacillus Calmette-Guerin and epirubicin versus bacillus Calmette-Guerin alone for superficial bladder tumors: A randomized prospective study [J].

Ali-El-Dein, B ;

Nabeeh, A ;

Ismail, EH ;

Ghoneim, MA .

JOURNAL OF UROLOGY, 1999, 162 (02) :339-342

[2] PREVENTIVE EFFECT OF A LACTOBACILLUS-CASEI PREPARATION ON THE RECURRENCE OF SUPERFICIAL BLADDER-CANCER IN A DOUBLE-BLIND TRIAL [J].

ASO, Y ;

AKAZA, H ;

KOTAKE, T ;

TSUKAMOTO, T ;

IMAI, K ;

NAITO, S .

EUROPEAN UROLOGY, 1995, 27 (02) :104-109

[3] Intravesical bacillus Calmette-Guerin treatment for stage T1 grade 3 transitional cell carcinoma of the bladder [J].

Baniel, J ;

Grauss, D ;

Engelstein, D ;

Sella, A .

UROLOGY, 1998, 52 (05) :785-789

[4] INTRAVESICAL ADJUVANT CHEMOTHERAPY FOR SUPERFICIAL TRANSITIONAL-CELL BLADDER-CARCINOMA - RESULTS OF 2 EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER RANDOMIZED TRIALS WITH MITOMYCIN-C AND DOXORUBICIN COMPARING EARLY VERSUS DELAYED INSTILLATIONS AND SHORT-TERM VERSUS LONG-TERM TREATMENT [J].

BOUFFIOUX, C ;

KURTH, KH ;

BONO, A ;

OOSTERLINCK, W ;

KRUGER, CB ;

DEPAUW, M ;

SYLVESTER, R ;

DENIS, L ;

NEWLING, D ;

HALL, R ;

BRESSEL, M ;

CASSELMAN, J ;

SMITH, P ;

ROBINSON, M ;

KEUPPENS, F ;

TOLLEY, D ;

JAKSE, G ;

BOLLACK, C ;

VERGISON, B ;

HOEKSTRA, W ;

DASILVA, FC ;

GROEN, J ;

RICHARDS, B ;

PAVONEMACALUSO, M ;

VANDERMEIJDEN, A ;

ZWARTENDIJK, H ;

JACOBI, G ;

VANCAUBERG, R ;

SCHRODER, F ;

HIRDES, D ;

LEISINGER, H ;

RIEDL, H ;

LUDWIG, P ;

ROOZENDAAL, K ;

MARECHAL, L ;

VANAUBEL, O ;

CONSIDINE, J ;

DEBRUYNE, F ;

CARREIRA, F ;

DEWALL, D ;

MENSINK, H ;

VIGGIANO, G .

JOURNAL OF UROLOGY, 1995, 153 (03) :934-941

[5] Long-term results of intravesical bacillus Calmette-Guerin therapy for stage T1 superficial bladder cancer [J].

Brake, M ;

Loertzer, H ;

Horsch, R ;

Keller, H .

UROLOGY, 2000, 55 (05) :673-678

[6] Urine cytology - Is it still the gold standard for screening? [J].

Brown, FM .

UROLOGIC CLINICS OF NORTH AMERICA, 2000, 27 (01) :25-+

[7] Local microwave hyperthermia and intravesical chemotherapy as bladder sparing treatment for select multifocal and unresectable superficial bladder tumors - Comment [J].

Campbell, SC .

JOURNAL OF UROLOGY, 1998, 159 (03) :787-787

[8] The treated natural history of high risk superficial bladder cancer: 15-year outcome [J].

Cookson, MS ;

Herr, HW ;

Zhang, ZF ;

Soloway, S ;

Sogani, PC ;

Fair, WR .

JOURNAL OF UROLOGY, 1997, 158 (01) :62-67

[9] The World Health Organization International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder [J].

Epstein, JI ;

Amin, MB ;

Reuter, VR ;

Mostofi, FK .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1998, 22 (12) :1435-1448

[10] Significance of bladder neck involvement on progression in superficial bladder cancer [J].

Fujii, Y ;

Fukui, I ;

Kihara, K ;

Tsujii, T ;

Ishizaka, K ;

Kageyama, Y ;

Kawakami, S ;

Oshima, H .

EUROPEAN UROLOGY, 1998, 33 (05) :464-468

← 1 2 3 4 5 →